FDA OKs InfraScan's next-gen device to detect brain bleeding

01/22/2013 | MassDevice.com (Boston)

The FDA has granted InfraScan approval for a next-generation version of its Infrascanner, which employs near-infrared technology to allow for the noninvasive detection of bleeding in the brain. The newly approved device, called the Infrascanner Model 2000, was created in collaboration with the U.S. Marine Corps and Navy and has military specifications, but it could also have applications in sports medicine and other fields.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA